Sanofi-Synthélabo, Via Messina, 38 – 20154 Milano (MI)
(from 01/04/2003 to 31/12/2004 = 2 years and 9 months)
In the TA (Therapeutic Area) «oncology»:
product specialist in 3 provinces in Northern Italy (Brescia, Trento and Bolzano, due to my mother tongue) for the brand ELOXATIN™ (oxaliplatin), an antineoplastic drug (anti-cancer medicine) used for the treatment of colorectal cancer (approved indication) and other types of gastrointestinal cancers
